Vortioxetine (Trintellix) Manufacturing Plant Project Report 2025

The report is the result of extensive primary and secondary research, offering a detailed analysis of current market trends, including the effects of COVID-19 on both global and regional scales. It profiles key industry players, giving insights into their market strategies, production capacities, and financial performance, which are crucial for benchmarking and competitive analysis.

It delves into historical, current, and forecasted price trends, helping stakeholders understand market dynamics and price volatility. The report provides a thorough analysis of the mass balance and raw materials requirements, ensuring a clear understanding of the input-output ratios essential for efficient production. Detailed examinations of the various unit operations integral to the vortioxetine (Trintellix) manufacturing process are included, highlighting process optimisation techniques and technological advancements.

The report presents a comprehensive capital cost analysis, detailing the financial investment required for setting up a vortioxetine (Trintellix) plant. This includes an exhaustive breakdown of costs associated with raw materials, catchem, utilities, labour, packaging, transportation, land acquisition, construction, and machinery. Additionally, it offers an in-depth look at the operating costs, providing clarity on the recurring expenses involved in running the plant.

Projected profit margins and optimal product pricing strategies are outlined, offering guidance on maximising profitability. The report also addresses regulatory frameworks, environmental impacts, and sustainability measures pertinent to the vortioxetine (Trintellix) industry.

About Vortioxetine (Trintellix)

Vortioxetine, sold under the brand name Trintellix, is an antidepressant medication used to treat major depressive disorder in adults. It is classified as a serotonin modulator and stimulator (SMS) and has a unique mechanism of action compared to other antidepressants. Vortioxetine carries a boxed warning about the increased risk of suicidal thoughts and behaviours in young adults. It is not approved for use in children. Vortioxetine has been shown to be effective in treating depression, with efficacy like other antidepressants. The most common side effects of vortioxetine include nausea, vomiting, constipation, and sexual dysfunction.

Properties of Vortioxetine (Trintellix)

Vortioxetine (Trintellix) is an antidepressant which has demonstrated cognitive-enhancing effects, meaning it can improve cognitive function in patients with major depressive disorder. Vortioxetine may also cause less emotional blunting compared to other antidepressants like SSRIs and SNRIs. Additionally, it has shown efficacy in treating anhedonia (lack of pleasure). It also has a unique pharmacological profile, acting as a serotonin modulator and stimulator, which contributes to its beneficial effects on mood and cognition. Commercially, Trintellix comes as an oral tablet in 5 mg, 10 mg, and 20 mg strengths.

Manufacturing Process of Vortioxetine (Trintellix)

The manufacturing process of vortioxetine (Trintellix) starts with formation of the piperazine ring, which is conducted under continuous flow conditions to improve productivity and scalability.  Next, the drug undergoes biotransformation, where it is metabolised by various enzymes, primarily CYP2D6, CYP3A4/5, and CYP2C9/19. The pharmacodynamic features of vortioxetine are also an important consideration in the manufacturing process, which are crucial for understanding the drug's mechanism of action and potential effects. Finally, the formulation development stage involves studying different formulations of vortioxetine to optimise its delivery and effectiveness.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Synthesis of Vortioxetine (Trintellix)

Step 1: Synthesis of 2-(2,4-dimethylphenylsulfanyl) benzoic acid

1. Starting Materials:

• 2,4-Dimethylphenylthiol: C8H10S

• 2-Chlorobenzoic acid: C7H5ClO2

   
2. Reaction:

• 2,4-Dimethylphenylthiol reacts with 2-chlorobenzoic acid in the presence of a base (such as NaOH) to form 2-(2,4-dimethylphenylsulfanyl) benzoic acid.

• C8H10S + C7H5ClO2 → C15H14O2S + HCl

Step 2: Synthesis of 1-(2,4-dimethylphenylthio)-2-(methylamino)ethane

1. Starting Materials:

• 2-(2,4-Dimethylphenylsulfanyl) benzoic acid: C15H14O2S

• Methylamine: CH5N

2. Reaction:

• The carboxyl group of 2-(2,4-dimethylphenylsulfanyl) benzoic acid is converted into an amide using methylamine.

• C15H14O2S + CH5N → C16H16NOS + H2O

Step 3: Cyclization to form 1-(2,4-dimethylphenylthio)-2-methylaminomethylbenzimidazole

1. Starting Materials:

• 1-(2,4-Dimethylphenylthio)-2-(methylamino) ethane: C16H16NOS

2. Reaction:

• Cyclization of the intermediate to form the benzimidazole ring.

• C16H16NOS → C17H18N2S + H2O

Step 4: Synthesis of Vortioxetine

1. Starting Materials:

• 1-(2,4-Dimethylphenylthio)-2-methylaminomethylbenzimidazole: C17H18N2S

• 3-Bromopyridine: C5H4BrN

2. Reaction:

• The benzimidazole intermediate reacts with 3-bromopyridine to form vortioxetine.

• C17H18N2S + C5H4BrN → C18H22BrN2S + HBr

Step 5. Final Product

The final product is vortioxetine (Trintellix) with a chemical formula as C18H22BrN2S.

Applications and Drivers of Vortioxetine (Trintellix)

Vortioxetine (Trintellix) is an antidepressant medication primarily used to treat major depressive disorder (MDD) in adults. Its mechanism of action involves increasing serotonin levels in the brain, although it also has other activities such as 5-HT3 receptor antagonism and 5-HT1A receptor agonism.

The most significant driver for vortioxetine is the prevalence of major depressive disorder. MDD is a serious form of depression that can significantly impact a person's quality of life. By effectively treating MDD, vortioxetine can help alleviate symptoms and improve overall well-being. Vortioxetine is also increasingly being considered for potential applications beyond MDD.

Key Features of the Vortioxetine (Trintellix) Production Cost Report:

This production cost analysis report by Expert Market Research scrutinises the vortioxetine (Trintellix) manufacturing process, offering a comprehensive overview necessary for stakeholders considering venturing into this sector. Based on the latest economic data, the report encompasses detailed insights into the primary process flow, raw material requirements, reactions involved, utility costs, operating costs, capital investments, pricing strategies, and profit margins. This report is an indispensable resource for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake in the vortioxetine (Trintellix) industry. It equips them with essential information and strategic insights to effectively navigate the complexities of the market.

The following sections detail the comprehensive scope of the prefeasibility report for a vortioxetine (Trintellix) production plant:

• Market Dynamics and Trends: This section analyses the prevailing market conditions, growth drivers, and trends impacting the vortioxetine (Trintellix) industry. It offers a thorough examination of demand fluctuations and projections.

• Impact of COVID-19: An assessment of how the pandemic has affected industry operations, supply chains, and overall market dynamics.

• Geographic Analysis: Detailed insights into the major regions active in vortioxetine (Trintellix) production and consumption, highlighting regional market specifics and growth potential.

• Key Industry Players: Profiles of leading manufacturers in the vortioxetine (Trintellix) sector, outlining their market share, strategic positions, and operational strengths.

• Price Fluctuations: Analysis of historical, current, and projected price trends, providing stakeholders with essential pricing intelligence.

• Technical Specifications and Process Description: A detailed overview of the vortioxetine (Trintellix) production process including the technology used and innovations within the industry.

• Raw Material Requirements and Sourcing: Evaluation of necessary raw materials, their sourcing strategies, and cost implications.

• Utility Requirements and Costs: Detailed analysis of utilities needed to produce vortioxetine (Trintellix), such as electricity, steam, and process water along with their cost assessments. 

• Labour Force Dynamics: Insights into manpower requirements, including skill specifications and labour cost projections.

• Packaging Needs: Overview of packaging requirements for vortioxetine (Trintellix) to ensure product integrity and cost efficiency.

• Logistics and Transportation: Examination of transportation needs and logistics planning for distribution and supply chain efficiency.

• Capital and Operating Costs: An in-depth look at investment requirements, including land acquisition and its development cost, civil work costs, construction, machinery procurement, and ongoing operational expenses, such as salaries and wages, plant overheads, tax and insurance as well as packaging, transportation, and administration costs.

• Financial Performance and Profitability Analysis: Projected profit margins and return on investment based on current market and operational parameters.

• Product Pricing Strategy: Recommendations on pricing mechanisms based on industry benchmarks and production costs.

• Environmental Impact and Regulatory Compliance: Analysis of environmental considerations and compliance with local and international regulations.

• Risk Assessment and Mitigation Strategies: Identification of potential risks associated with vortioxetine (Trintellix) production and strategies to mitigate them.

Key Questions Addressed:

• What are the detailed unit operations for vortioxetine (Trintellix) production?

• Who are major technology licensors with their process evaluation?

• How are raw materials or catchem procured and what are their cost implications?

• What utilities are essential for production and what will they cost?

• What are the labour requirements and how does this affect operational costs?

• What packaging solutions are optimal for cost and efficiency?

• What logistical arrangements are necessary for efficient product distribution?

• What are the estimated land and construction costs for a new vortioxetine (Trintellix) plant?

• How can profitability be maximised in the vortioxetine (Trintellix) market?

• What pricing strategy should be adopted for vortioxetine (Trintellix) to remain competitive?

This prefeasibility report aims to equip potential investors and existing manufacturers with crucial insights to make informed decisions in the vortioxetine (Trintellix) industry.